Covalent inhibitors react with amino acid residues in the active site of enzymes to form strong, often irreversible interactions. They have advantages like increased potency and longer duration but also risks like lack of selectivity and idiosyncratic reactions. Examples of clinically used covalent inhibitors include aspirin, which acetylates COX enzymes, β-lactam antibiotics that form adducts with transpeptidases, and proton pump inhibitors like omeprazole that covalently inhibit H+/K+ ATPases. Due to their reactivity, covalent inhibitors require careful evaluation of selectivity against off-target enzymes.
A comprehensive presentation on Enzymology :Types of Enzyme inhibition & Therapeutic uses for MBBS ,BDS, B Pharm & Biotechnology students to facilitate self- study.
1. Cholinergic drugs act as agonists at cholinergic receptors and include direct-acting receptor agonists like acetylcholine and indirect-acting cholinesterase inhibitors.
2. Direct-acting agonists can be classified based on their receptor specificity and susceptibility to acetylcholinesterase hydrolysis. Indirect agonists inhibit acetylcholinesterase and butyrylcholinesterase to prolong the action of endogenous acetylcholine.
3. Cholinergic drugs have various effects in the body including contraction of muscles in the eye, increased secretions, changes in heart rate and breathing, and activation of the parasympathetic nervous system. Their effects are mediated through muscar
1) Enzyme inhibition occurs when a compound decreases the rate of an enzyme-catalyzed reaction by binding to the enzyme and altering its catalytic activity.
2) There are several types of enzyme inhibition including competitive, non-competitive, irreversible, and allosteric inhibition. Competitive inhibitors bind to the enzyme's active site, non-competitive inhibitors bind elsewhere, and irreversible inhibitors bind permanently through covalent bonds.
3) Allosteric inhibition involves binding at allosteric sites which induces a conformational change that decreases catalytic activity, and feedback inhibition occurs when a product of a pathway inhibits an earlier enzyme in the pathway.
This document discusses different types of enzyme inhibition. It defines inhibitors as substances that inactivate enzymes without altering pH or ionic strength. Inhibition can be reversible or irreversible. There are three main types of reversible inhibition - competitive, non-competitive, and uncompetitive. Competitive inhibitors resemble the substrate and bind the active site. Non-competitive inhibitors bind elsewhere and reduce reaction rate. Uncompetitive inhibitors bind the enzyme-substrate complex. The document provides examples of clinically relevant competitive inhibitors and discusses suicide inhibition which uses the enzyme's reaction to irreversibly inactivate it.
Mechanism of drug action,drug receptor phrmacologyReena Gollapalli
includes various types of receptors, mechanism of action, factors modifying drug action,principles of drug action,all types of drug receptor complex interactions very useful to students and post graduates..
Environmental factors such as temperature, pH, and concentrations of enzymes, substrates, and products can affect the rate of enzyme-catalyzed reactions. Enzyme activity is also regulated by cofactors, allosteric effectors, covalent modification, and induction/repression of enzyme synthesis. Enzymes exhibit varying degrees of specificity, from absolute specificity for a single substrate to bond or group specificity for classes of substrates. Isoenzymes are variants of the same enzyme found in different tissues.
A comprehensive presentation on Enzymology :Types of Enzyme inhibition & Therapeutic uses for MBBS ,BDS, B Pharm & Biotechnology students to facilitate self- study.
1. Cholinergic drugs act as agonists at cholinergic receptors and include direct-acting receptor agonists like acetylcholine and indirect-acting cholinesterase inhibitors.
2. Direct-acting agonists can be classified based on their receptor specificity and susceptibility to acetylcholinesterase hydrolysis. Indirect agonists inhibit acetylcholinesterase and butyrylcholinesterase to prolong the action of endogenous acetylcholine.
3. Cholinergic drugs have various effects in the body including contraction of muscles in the eye, increased secretions, changes in heart rate and breathing, and activation of the parasympathetic nervous system. Their effects are mediated through muscar
1) Enzyme inhibition occurs when a compound decreases the rate of an enzyme-catalyzed reaction by binding to the enzyme and altering its catalytic activity.
2) There are several types of enzyme inhibition including competitive, non-competitive, irreversible, and allosteric inhibition. Competitive inhibitors bind to the enzyme's active site, non-competitive inhibitors bind elsewhere, and irreversible inhibitors bind permanently through covalent bonds.
3) Allosteric inhibition involves binding at allosteric sites which induces a conformational change that decreases catalytic activity, and feedback inhibition occurs when a product of a pathway inhibits an earlier enzyme in the pathway.
This document discusses different types of enzyme inhibition. It defines inhibitors as substances that inactivate enzymes without altering pH or ionic strength. Inhibition can be reversible or irreversible. There are three main types of reversible inhibition - competitive, non-competitive, and uncompetitive. Competitive inhibitors resemble the substrate and bind the active site. Non-competitive inhibitors bind elsewhere and reduce reaction rate. Uncompetitive inhibitors bind the enzyme-substrate complex. The document provides examples of clinically relevant competitive inhibitors and discusses suicide inhibition which uses the enzyme's reaction to irreversibly inactivate it.
Mechanism of drug action,drug receptor phrmacologyReena Gollapalli
includes various types of receptors, mechanism of action, factors modifying drug action,principles of drug action,all types of drug receptor complex interactions very useful to students and post graduates..
Environmental factors such as temperature, pH, and concentrations of enzymes, substrates, and products can affect the rate of enzyme-catalyzed reactions. Enzyme activity is also regulated by cofactors, allosteric effectors, covalent modification, and induction/repression of enzyme synthesis. Enzymes exhibit varying degrees of specificity, from absolute specificity for a single substrate to bond or group specificity for classes of substrates. Isoenzymes are variants of the same enzyme found in different tissues.
Isozymes are enzymes that differ in amino acid sequence but catalyze the same chemical reaction, while allozymes represent enzymes from different alleles of the same gene. An example of an isozyme is glucokinase, a variant of hexokinase that is not inhibited by glucose 6-phosphate and serves different functions in specific organs. Enzyme inhibitors can be competitive, noncompetitive, uncompetitive, or irreversible depending on whether they bind to the enzyme's active site and how their binding affects the enzyme's kinetic parameters. Many drugs act as enzyme inhibitors to treat diseases, such as statins that competitively inhibit HMG-CoA reductase to lower cholesterol or ACE inhibitors that lower blood pressure by inhibiting
The document discusses different types of enzyme inhibition. There are three broad categories of enzyme inhibition: reversible, irreversible, and allosteric inhibition. Reversible inhibition includes competitive, non-competitive, and uncompetitive inhibition. Competitive inhibitors bind to the enzyme's active site, preventing substrate binding. Non-competitive inhibitors bind elsewhere, altering the enzyme's shape. Uncompetitive inhibitors only bind to the enzyme-substrate complex. Irreversible inhibitors covalently bind the enzyme, permanently inactivating it. Many drugs work by competitively or non-competitively inhibiting key enzymes.
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
1) Receptors are specific macromolecular proteins that interact with drugs to produce changes in biological systems. Receptors have drug-binding sites and biologically active sites, and determine quantitative drug effects. Receptors mediate actions of agonists and antagonists.
2) Agonists fully or partially activate receptors to produce responses resembling endogenous ligands. Full agonists have maximal efficacy while partial agonists have submaximal efficacy. Inverse agonists decrease constitutive receptor activity.
3) Some drugs act through non-receptor mediated mechanisms like interfering with ion passage through cell membranes, inhibiting enzymes or transport processes, or directly interacting with molecules outside cells.
Metabolism of drugs can sometimes produce toxic reactions through reactive intermediates, especially at high doses that overwhelm detoxification pathways. Acetaminophen is normally safely metabolized but an overdose can cause hepatotoxicity by depleting glutathione reserves. Administering N-acetylcysteine within 16 hours of overdose can prevent liver damage. Individual differences in drug metabolism due to genetic and non-genetic factors affect dosing needs and toxicity risks. Careful consideration of these factors is clinically relevant for safe drug use.
This document discusses enzyme inhibition as it relates to drug discovery. It begins by providing background on the target-based approach to drug discovery, noting that enzymes are excellent drug targets. It then discusses different drug discovery approaches and the multi-stage drug discovery process. Several sections provide examples of enzyme inhibitors that are used as drugs to treat various diseases and medical conditions. The mechanisms of reversible and irreversible enzyme inhibition are also summarized. Finally, specific classes of enzyme inhibitors are discussed in more detail, such as kinase inhibitors, ACE inhibitors to treat hypertension, and statin drugs to lower cholesterol.
This document discusses the principles of how medications produce their effects in the body. It describes four main types of medication actions: stimulation, depression, irritation, and replacement. It then explains features of medication effects such as dose-response relationships and interactions with receptors, enzymes, cell membranes, and direct physical or chemical actions. The key mechanisms discussed are agonism, antagonism, enzyme inhibition or stimulation, effects on ion channels, and carrier transport blockade.
This document provides an overview of anti-hyperlipidemic agents. It discusses the classification of these agents and covers several classes in detail, including HMG-CoA reductase inhibitors (statins), fibric acid derivatives, and bile acid sequestrants. For each class, it describes the mechanism of action, structure-activity relationships, examples of drugs, pharmacokinetics, adverse effects, and therapeutic uses. Key drugs discussed include simvastatin, lovastatin, clofibrate, gemfibrozil, cholestyramine, and colestipol. The document aims to provide students with information on the subject of medicinal chemistry as it relates to anti-hyperlipidemic
This power-point presentation will give a complete overview about enzymes, nomenclature of enzymes. Enzymes inhibition is also covered in this ppt. Along with some basin introduction to G- protein coupled receptors is also provided.
Enzymes are biological catalysts that speed up chemical reactions without being consumed. They are typically proteins that act by lowering the activation energy of reactions. Enzymes achieve a high degree of reaction specificity by possessing an active site that only certain substrates can fit into. The document provides an overview of enzymes, including how they are named, regulated, and can be competitive or noncompetitively inhibited. Key features like optimal pH and temperature ranges are also summarized.
The document discusses enzymes and their properties. It begins by defining enzymes as biological catalysts and describes their characteristics, including that they are not used up in chemical reactions. It then covers enzyme structure and function, classification, regulation, and clinical significance. Key points include: enzymes have an active site that facilitates reactions; there are multiple levels of enzyme classification based on the type of reaction catalyzed; factors like temperature, pH, and inhibitors can impact enzyme activity; isozymes and zymogens are discussed. Measurement of plasma enzyme levels is also described as being diagnostically useful.
This document discusses the basic types and mechanisms of drug action. It describes five basic types of drug action: stimulation, depression, irritation, replacement, and cytotoxic action. It then provides examples and explanations of each type. The document also discusses the mechanisms of drug action, including interaction with target biomolecules like enzymes, ion channels, transporters, and receptors. Agonists, antagonists, and other receptor interactions are explained in detail. Non-receptor mechanisms like changing physical properties and cell membrane permeability are also covered.
The document discusses the structure, properties, and mechanisms of enzyme action. It defines enzymes as protein catalysts that speed up biochemical reactions without being consumed. Enzymes have an active site that binds to specific substrates. The mechanisms of enzyme action include lowering the activation energy of reactions and processes at the active site. Enzyme activity can be regulated by factors like pH, temperature, allosteric regulation, covalent modification, and inhibition. Isoenzymes are multiple forms of the same enzyme that catalyze the same reaction.
To be able to describe:
Cholesterol synthesis, source & metabolism
Hyperlipidemia – definition & normal values.
Anti hyperlipidemic drugs: its classification, mechanism of action & side effects.
The natural history of atherosclerosis might involve coronary plaque rupture / erosion, thrombus formation and vessel lumen occlusion, clinically recognized as acute coronary syndrome (ACS). International guidelines strongly recommend early statin administration in patients admitted for ACS. In addition to lowering circulating levels of low-density lipoprotein cholesterol (LDL-c), statin treatment was shown to promote plaque stabilization or regression in several ways, including reduction in necrotic lipid core, anti-inflammatory effects and improvement in endothelial function.
Update on the efficacy of statin treatment in acute coronary syndromes by Rosa, Gian Marco; Carbone, Federico; Parodi, Antonello; Massimelli, Elena A; Brunelli, Claudio; Mach, François (more...) European journal of clinical investigation, 05/2014, Volume 44, Issue 5, 501 - 515
Cholinergic agonists mimic acetylcholine by directly binding to cholinergic receptors or indirectly by inhibiting acetylcholinesterase. Direct-acting agonists include acetylcholine, bethanechol, carbachol, methacholine, nicotine, and pilocarpine. Indirect-acting agonists reversibly or irreversibly inhibit acetylcholinesterase, prolonging the actions of endogenous acetylcholine. Common indirect agonists are neostigmine, physostigmine, and organophosphates. Cholinergic agonists have widespread effects throughout the body and can be used to treat various conditions like glaucoma, urinary retention, and myasthenia gravis
ENZYME INHIBITION THE MOST IMPORTANT TOPIC FOR BIOLOGY AS WELL AS CHEMISTRY PEOPLES. WE HAVE HERE COVERED FOR THE PHARMA STUDENTS THIS WILL MAKE THEM EASY AS WE ARE COLLECTED ALL THE DATA A SINGLE PLACE WICH COVERS ALL THE COTENTS.
This document provides an overview of pharmacodynamics, which is the study of how drugs act on the body. It discusses the basic types of drug action like stimulation, depression, irritation, replacement, and cytotoxic effects. It then explains the main mechanisms of drug action, including interaction with enzymes, ion channels, transporters, and receptors. Receptors are categorized into G protein-coupled, ion channel, transmembrane enzyme-linked, JAK-STAT binding, and nuclear/transcription factor receptors. The concepts of drug potency, efficacy, therapeutic index, synergism, antagonism, and competitive and noncompetitive receptor antagonism are also introduced.
Enzymes can be inhibited through competitive or non-competitive inhibition. Competitive inhibitors resemble the substrate and bind to the enzyme's active site, increasing the Km but not affecting Vmax. Non-competitive inhibitors bind elsewhere on the enzyme, decreasing Vmax but not changing Km. These effects can be seen through Michaelis-Menten and Lineweaver-Burk plots. Many drugs work as competitive inhibitors. Non-competitive inhibition can occur through interfering with cofactors, metal ion activators, or sulfhydryl groups.
slide consist of cholinergic system, neuronal transmission, receptors of cholinergic system, anti cholinergic drugs its classification, Mechanism of action and organophosphate poisoning and treatment approaches
Isozymes are enzymes that differ in amino acid sequence but catalyze the same chemical reaction, while allozymes represent enzymes from different alleles of the same gene. An example of an isozyme is glucokinase, a variant of hexokinase that is not inhibited by glucose 6-phosphate and serves different functions in specific organs. Enzyme inhibitors can be competitive, noncompetitive, uncompetitive, or irreversible depending on whether they bind to the enzyme's active site and how their binding affects the enzyme's kinetic parameters. Many drugs act as enzyme inhibitors to treat diseases, such as statins that competitively inhibit HMG-CoA reductase to lower cholesterol or ACE inhibitors that lower blood pressure by inhibiting
The document discusses different types of enzyme inhibition. There are three broad categories of enzyme inhibition: reversible, irreversible, and allosteric inhibition. Reversible inhibition includes competitive, non-competitive, and uncompetitive inhibition. Competitive inhibitors bind to the enzyme's active site, preventing substrate binding. Non-competitive inhibitors bind elsewhere, altering the enzyme's shape. Uncompetitive inhibitors only bind to the enzyme-substrate complex. Irreversible inhibitors covalently bind the enzyme, permanently inactivating it. Many drugs work by competitively or non-competitively inhibiting key enzymes.
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
1) Receptors are specific macromolecular proteins that interact with drugs to produce changes in biological systems. Receptors have drug-binding sites and biologically active sites, and determine quantitative drug effects. Receptors mediate actions of agonists and antagonists.
2) Agonists fully or partially activate receptors to produce responses resembling endogenous ligands. Full agonists have maximal efficacy while partial agonists have submaximal efficacy. Inverse agonists decrease constitutive receptor activity.
3) Some drugs act through non-receptor mediated mechanisms like interfering with ion passage through cell membranes, inhibiting enzymes or transport processes, or directly interacting with molecules outside cells.
Metabolism of drugs can sometimes produce toxic reactions through reactive intermediates, especially at high doses that overwhelm detoxification pathways. Acetaminophen is normally safely metabolized but an overdose can cause hepatotoxicity by depleting glutathione reserves. Administering N-acetylcysteine within 16 hours of overdose can prevent liver damage. Individual differences in drug metabolism due to genetic and non-genetic factors affect dosing needs and toxicity risks. Careful consideration of these factors is clinically relevant for safe drug use.
This document discusses enzyme inhibition as it relates to drug discovery. It begins by providing background on the target-based approach to drug discovery, noting that enzymes are excellent drug targets. It then discusses different drug discovery approaches and the multi-stage drug discovery process. Several sections provide examples of enzyme inhibitors that are used as drugs to treat various diseases and medical conditions. The mechanisms of reversible and irreversible enzyme inhibition are also summarized. Finally, specific classes of enzyme inhibitors are discussed in more detail, such as kinase inhibitors, ACE inhibitors to treat hypertension, and statin drugs to lower cholesterol.
This document discusses the principles of how medications produce their effects in the body. It describes four main types of medication actions: stimulation, depression, irritation, and replacement. It then explains features of medication effects such as dose-response relationships and interactions with receptors, enzymes, cell membranes, and direct physical or chemical actions. The key mechanisms discussed are agonism, antagonism, enzyme inhibition or stimulation, effects on ion channels, and carrier transport blockade.
This document provides an overview of anti-hyperlipidemic agents. It discusses the classification of these agents and covers several classes in detail, including HMG-CoA reductase inhibitors (statins), fibric acid derivatives, and bile acid sequestrants. For each class, it describes the mechanism of action, structure-activity relationships, examples of drugs, pharmacokinetics, adverse effects, and therapeutic uses. Key drugs discussed include simvastatin, lovastatin, clofibrate, gemfibrozil, cholestyramine, and colestipol. The document aims to provide students with information on the subject of medicinal chemistry as it relates to anti-hyperlipidemic
This power-point presentation will give a complete overview about enzymes, nomenclature of enzymes. Enzymes inhibition is also covered in this ppt. Along with some basin introduction to G- protein coupled receptors is also provided.
Enzymes are biological catalysts that speed up chemical reactions without being consumed. They are typically proteins that act by lowering the activation energy of reactions. Enzymes achieve a high degree of reaction specificity by possessing an active site that only certain substrates can fit into. The document provides an overview of enzymes, including how they are named, regulated, and can be competitive or noncompetitively inhibited. Key features like optimal pH and temperature ranges are also summarized.
The document discusses enzymes and their properties. It begins by defining enzymes as biological catalysts and describes their characteristics, including that they are not used up in chemical reactions. It then covers enzyme structure and function, classification, regulation, and clinical significance. Key points include: enzymes have an active site that facilitates reactions; there are multiple levels of enzyme classification based on the type of reaction catalyzed; factors like temperature, pH, and inhibitors can impact enzyme activity; isozymes and zymogens are discussed. Measurement of plasma enzyme levels is also described as being diagnostically useful.
This document discusses the basic types and mechanisms of drug action. It describes five basic types of drug action: stimulation, depression, irritation, replacement, and cytotoxic action. It then provides examples and explanations of each type. The document also discusses the mechanisms of drug action, including interaction with target biomolecules like enzymes, ion channels, transporters, and receptors. Agonists, antagonists, and other receptor interactions are explained in detail. Non-receptor mechanisms like changing physical properties and cell membrane permeability are also covered.
The document discusses the structure, properties, and mechanisms of enzyme action. It defines enzymes as protein catalysts that speed up biochemical reactions without being consumed. Enzymes have an active site that binds to specific substrates. The mechanisms of enzyme action include lowering the activation energy of reactions and processes at the active site. Enzyme activity can be regulated by factors like pH, temperature, allosteric regulation, covalent modification, and inhibition. Isoenzymes are multiple forms of the same enzyme that catalyze the same reaction.
To be able to describe:
Cholesterol synthesis, source & metabolism
Hyperlipidemia – definition & normal values.
Anti hyperlipidemic drugs: its classification, mechanism of action & side effects.
The natural history of atherosclerosis might involve coronary plaque rupture / erosion, thrombus formation and vessel lumen occlusion, clinically recognized as acute coronary syndrome (ACS). International guidelines strongly recommend early statin administration in patients admitted for ACS. In addition to lowering circulating levels of low-density lipoprotein cholesterol (LDL-c), statin treatment was shown to promote plaque stabilization or regression in several ways, including reduction in necrotic lipid core, anti-inflammatory effects and improvement in endothelial function.
Update on the efficacy of statin treatment in acute coronary syndromes by Rosa, Gian Marco; Carbone, Federico; Parodi, Antonello; Massimelli, Elena A; Brunelli, Claudio; Mach, François (more...) European journal of clinical investigation, 05/2014, Volume 44, Issue 5, 501 - 515
Cholinergic agonists mimic acetylcholine by directly binding to cholinergic receptors or indirectly by inhibiting acetylcholinesterase. Direct-acting agonists include acetylcholine, bethanechol, carbachol, methacholine, nicotine, and pilocarpine. Indirect-acting agonists reversibly or irreversibly inhibit acetylcholinesterase, prolonging the actions of endogenous acetylcholine. Common indirect agonists are neostigmine, physostigmine, and organophosphates. Cholinergic agonists have widespread effects throughout the body and can be used to treat various conditions like glaucoma, urinary retention, and myasthenia gravis
ENZYME INHIBITION THE MOST IMPORTANT TOPIC FOR BIOLOGY AS WELL AS CHEMISTRY PEOPLES. WE HAVE HERE COVERED FOR THE PHARMA STUDENTS THIS WILL MAKE THEM EASY AS WE ARE COLLECTED ALL THE DATA A SINGLE PLACE WICH COVERS ALL THE COTENTS.
This document provides an overview of pharmacodynamics, which is the study of how drugs act on the body. It discusses the basic types of drug action like stimulation, depression, irritation, replacement, and cytotoxic effects. It then explains the main mechanisms of drug action, including interaction with enzymes, ion channels, transporters, and receptors. Receptors are categorized into G protein-coupled, ion channel, transmembrane enzyme-linked, JAK-STAT binding, and nuclear/transcription factor receptors. The concepts of drug potency, efficacy, therapeutic index, synergism, antagonism, and competitive and noncompetitive receptor antagonism are also introduced.
Enzymes can be inhibited through competitive or non-competitive inhibition. Competitive inhibitors resemble the substrate and bind to the enzyme's active site, increasing the Km but not affecting Vmax. Non-competitive inhibitors bind elsewhere on the enzyme, decreasing Vmax but not changing Km. These effects can be seen through Michaelis-Menten and Lineweaver-Burk plots. Many drugs work as competitive inhibitors. Non-competitive inhibition can occur through interfering with cofactors, metal ion activators, or sulfhydryl groups.
slide consist of cholinergic system, neuronal transmission, receptors of cholinergic system, anti cholinergic drugs its classification, Mechanism of action and organophosphate poisoning and treatment approaches
KALYAN MATKA | MATKA RESULT | KALYAN MATKA TIPS | SATTA MATKA | MATKA.COM | MATKA PANA JODI TODAY | BATTA SATKA | MATKA PATTI JODI NUMBER | MATKA RESULTS | MATKA CHART | MATKA JODI | SATTA COM | FULL RATE GAME | MATKA GAME | MATKA WAPKA | ALL MATKA RESULT LIVE ONLINE | MATKA RESULT | KALYAN MATKA RESULT | DPBOSS MATKA 143 | MAIN MATKA
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka ! Fix Satta Matka ! Matka Result ! Matka Guessing ! Final Matka ! Matka Result ! Dpboss Matka ! Matka Guessing ! Satta Matta Matka 143 ! Kalyan Matka ! Satta Matka Fast Result ! Kalyan Matka Guessing ! Dpboss Matka Guessing ! Satta 143 ! Kalyan Chart ! Kalyan final ! Satta guessing ! Matka tips ! Matka 143 ! India Matka ! Matka 420 ! matka Mumbai ! Satta chart ! Indian Satta ! Satta King ! Satta 143 ! Satta batta ! Satta मटका ! Satta chart ! Matka 143 ! Matka Satta ! India Matka ! Indian Satta Matka ! Final ank
This tutorial offers a step-by-step guide on how to effectively use Pinterest. It covers the basics such as account creation and navigation, as well as advanced techniques including creating eye-catching pins and optimizing your profile. The tutorial also explores collaboration and networking on the platform. With visual illustrations and clear instructions, this tutorial will equip you with the skills to navigate Pinterest confidently and achieve your goals.
❼❷⓿❺❻❷❽❷❼❽ Dpboss Kalyan Satta Matka Guessing Matka Result Main Bazar chart Final Matka Satta Matta Matka 143 Kalyan Chart Satta fix Jodi Kalyan Final ank Matka Boss Satta 143 Matka 420 Golden Matka Final Satta Kalyan Penal Chart Dpboss 143 Guessing Kalyan Night Chart
The cherry: beauty, softness, its heart-shaped plastic has inspired artists since Antiquity. Cherries and strawberries were considered the fruits of paradise and thus represented the souls of men.
Heart Touching Romantic Love Shayari In English with ImagesShort Good Quotes
Explore our beautiful collection of Romantic Love Shayari in English to express your love. These heartfelt shayaris are perfect for sharing with your loved one. Get the best words to show your love and care.
1. 1
Rational Drug Design
lecture 7
Łukasz Berlicki
Enzyme inhibitors
Covalent - react with amino acid residues of the
enzyme. Covalent inhibitors may be irreversible or
reversible.
Non-covalent - interact with the enzyme.
Covalent inhibitors may react with:
nucleophiles of the active site (involved in the enzymatic
reaction) - mechanism-based inhibitors;
nucleophiles near active site -Targeted covalent inhibitors
(TCI).
2. 2
Covalent inhibitors
Advantages
strong interaction with the enzyme,often irreversible;
combination of non-covalent (specificity) and covalent (high energy)
interactions;
increased biochemical efficiency:
Non-equilibrium constraints restrict competition with natural
substrates of ligands;
Slow removal from the body;
Lower doses required;
If the target is deactivated rapidly, drug concentration is rapidly reduced
and drug toxicity and drug interactions are limited.
Potentially longer action time depending on the synthesis of new
enzyme (less dosage).
The most effective strategy for goals that require complete
deactivation.
Covalent inhibitors
Disadvantages
Greater probability of the lack of selectivity;
Potential immunogenicity of protein adduct with ligand leading to
allergic response;
idiosyncratic reaction (hypersensitivity);
Possible problems with reactive metabolic products;
Not suitable for molecular purposes requiring short-acting or partial
inhibition;
3. 3
Covalent inhibitors
Idiosyncrasia (gr. Ιδιοσυγκρασία, idiosynkrasia, idios "his
own" and syn-krasis "mixture") - state of increased organism's
perception of a particular chemical compound.
Drug response, associated with individual sensitivity, is due to
abnormalities in the biochemical metabolism of the drug in the
body: abnormal metabolism, accumulation or blocking of
metabolism of other substances.
This is not an allergic reaction (no antigen-antibody
interaction).
Covalent inhibitors
Due to the difficult to predict side effects, covalent inhibitors are
reluctantly used as leading substances in pharmaceutical projects.
Most of the covalent inhibitors used were commercially available
prior to the discovery of their covalent mechanism of action.
Approx. 30% of the enzyme inhibitors used act by covalent
modification of molecular target.
infections
cancer
Gastric tract
CNS
Circulatury system
Anti-inflamatry
other
4. 4
Covalent inhibitors
The simplest way to design:
Fragment analogous to the substrate,
group reacting with Ser or Cys
residues in active site or its
surroundings.
warhead
Covalent inhibitors
Nucleophiles in enzyme:
Cys, -SH
Ser, -OH
Electrophiles in inhibitor:
Acylation reaction
Alkylation reaction
Addition
5. 5
Covalent inhibitors
Nucleophile - a group with an excess of electrons, which in
reaction can be an electron donor:
-SH
-OH
Electrophile - an electron deficient group that reacts with
electron acceptor:
The electrophile can not be too reactive (can not react with
water).
Covalent inhibitors
Acylation or phosphonylation of serine
or
or
8. 8
Acetylcholinesterase inhibitors
Sarin was discovered in
Germany in 1938 (IG Farben)
in research aimed at finding
pesticides.
Since 1939 Germany
produced sarin and its
analogues as chemical
weapons (never used by
them).
The name sarin comes from
the names of the discoverers:
Schrader, Ambros, Rüdiger i
Van der Linde.
sarin
soman
tabun
cyclosarin
VX
Acetylcholinesterase inhibitors
Sarin was used in 1988 against Kurds in Iraq (5,000 victims).
In 1995, sarin was used in the assassination of the metro in
Tokyo by the sect of the Supreme Truth.
9. 9
Acetylcholinesterase inhibitors
The high toxicity of
paralytic-convulsive fighting
gases: sarin, soman,
cyclosarin, tabun andVX
results from their
irreversible inhibition of
acetylcholinesterase.
LD50 = 172 μg/kg
Acetylcholinesterase inhibitors
Inhibitors react with the rest
of the serine at the active site
of the enzyme.
10. 10
Acetylcholinesterase inhibitors
Myasthenia gravis - An
autoimmune disease
characterized by rapid pain in the
skeletal muscles. It is associated
with blockade of acetylcholine
receptors.
Medicines are reversible
covalent acetylcholinesterase
inhibitors. Neostygmin
Pirydostygmin
Acetylcholinesterase inhibitors
Neostygmine
Pirydostygmine
11. 11
Aspirin
Aspirin is an irreversible
covalent cyclooxygenase
inhibitor of COX-1 and
COX-2.
Cyclooxygenases catalyze the
synthesis of prostaglandin
from arachidonic acid.
Aspirin
Aspirin acetylates the serine residue at the active site of the
enzyme.
12. 12
β-lactames
β-lactam antibiotics are
irreversible D-Ala-D-Ala-
transpeptidase inhibitors.
They form a stable adduct
to the Ser residue at the
active site of the
transpeptidase.
Penicillins are effectively
hydrolysed by β-lactamase
Tanspeptidase β-lactamase
Clavulanic acid
Clavulanic acid is an
irreversible inhibitor of β-
lactamase.
Clavulanic acid was isolated
from the Streptomuces
clavuligerus bacteria.
It is used together with β-
lactam antibiotics.
β-lactamase
13. 13
Fosfomycin
Fosfomycin was isolated from
Streptomyces bacteria.
It is a covalent MurA inhibitor - UDP-
N-acetylglucosamine enolpyruvyl
transferase.
Enzyme is essential for the biosynthesis
of peptidoglycan - the bacterial cell wall
component.
Fosfomycin
Fosfomycin is an effective antibiotic used to treat urinary tract
infections.
Typically, 1 mega-dose (2-3 g of medicine) is taken.
Fosfomycin reacts with Cys115 enzyme to form covalent
adduct.
14. 14
Fosfomycin
fatty acid amides hydrolase
The main substrate for fatty
acid hydrolase (FAAH) is
anandamide.
Anandamide is
endocannabinoid.
Anandamide activates
cannabinoid receptors CB1
and CB2.
Anandamide has similar
activity to THC.
Anadamide
(Sanskrit, ananda – happiness)
15. 15
FAAH
FAAH - is the molecular target of painkillers.
Failure of FAAH results in increased anadamide
concentrations and hence analgesic effect.
FAAH inhibition does not have side effects observed with
direct activation of CB1 and CB2 receptors (recognition
and motor dysfunction).
FAAH
Mechanism of hydrolysis
18. 18
FAAH inhibitors
Compound PF-04457845 is in Phase II clinical trials as a
painkiller
Lipostatin
Lipostatin is an irreversible inhibitor
of pancreatic lipase.
Lipostatin was isolated from
Streptomyces toxytricini bacteria.
The β-lactone system reacts with the
Ser residue at the active site of the
enzyme.
19. 19
Lipostatin
Saturated lipostatin analogue - orlistat is a commercially
available drug for obesity.
Inhibition of lipase enzyme activity reduces the absorption of
fats.
With no additional treatments (exercise and diet) the effect
of the drug is moderate: about 2-3kg per year.
orlistat
Lipostatin - orlistat
20. 20
Proton pump inhibitors
In gastric and duodenal ulcers and gastroesophageal reflux disease, it
is desirable to reduce the acidic effect of gastric juice.
Inhibition of H + / K + ATPase (proton pump) in cells
of the stomach causes
reduction of secretion
hydrogen ions.
Proton pump inhibitors
Omeprazole and its analogues are covalent ATPase
inhibitors.
21. 21
Checking selectivity
Because of the reactivity of covalent inhibitors, it is
necessary to check their selectivity for all enzymes in a
given class.
Tests can be performed using substances that detect
activity-based probes.
Checking selectivity
22. 22
Summary
Irreversible enzyme inhibitors are an important class of
widely used drugs.
Irreversible inhibitors have many advantages over non-
equilibrium behavior with respect to the enzyme.
They can cause difficult to predict side effects.